Transdermal oxygen delivery to increase systemic oxygen supply for COVID-19 patients having no access to lung ventilators or patients where lung ventilators are not sufficient
- Funded by Volkswagen Stiftung
- Total publications:244 publications
Grant number: Unknown
Grant search
Key facts
Disease
COVID-19start year
2020Funder
Volkswagen StiftungPrincipal Investigator
Profs Drs Lars Kaestner, Anna Bogdanova, Matthias LaschkeResearch Location
GermanyLead Research Institution
Universität des Saarlandes Medizinische Fakultät Theoretische Medizin und Biowissenschaften Homburg/Saar Universität Zürich Vetsuisse Fakultät Institut für Veterinärphysiologie Zürich SchweizResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The goal of the project "Transdermal oxygen delivery to increase systemic oxygen supply for COVID-19 patients having no access to lung ventilators or patients where lung ventilators are not sufficient" is to test whether oxygen supply through the skin treated with gels containing oxygen-concentrating fluorocarbons may result in better oxygenation of blood under conditions of poor oxygen absorption through the lungs. A successful proof of principle may open the possibility to supplement part of the oxygen to the body by way of transcutaneous delivery for patients on ventilation due to atypical pneumonia, such as Covid-19 infected patients, for which ventilation with pure oxygen is of little help due to an increase diffusion distance emerging during the inflammation.
Publicationslinked via Europe PMC
Last Updated:5 days ago
View all publications at Europe PMC